You must be logged in to post a comment.
The Brazilian regulatory Agency, Anvisa (Agência Nacional de Vigilância Sanitária) issues market authorizations for medical devices and pharmaceuticals; exercises post-marketing […]
Patient safety is a critical aspect of the Healthcare Industry that involves protecting patients from harm and ensuring that they […]
When it comes to developing nonproprietary names for pharmaceuticals and biologics, the goal remains consistent: to obtain an appropriate name […]
The “Nonproprietary Naming of Biological Products” draft guidance was published by the Food and Drug Administration (FDA) in August 2015 […]
